{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:54:56Z","timestamp":1781848496675,"version":"3.54.5"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Among adults, there is a constant increase in the incidence of non-alcoholic fatty liver disease (NAFLD). The significant limitations of available pharmacological therapies for this condition have led to intensive research into natural bioactive compounds with hepatoprotective properties. Therefore, this study focused on evaluating the effects of astaxanthin and kokum supplementation on lipid peroxidation levels, fatty acid profile, and lysosomal activity in mice liver with diet-induced NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study was conducted using 120 male Swiss Webster mice. A methionine- and choline-deficient (MCD) diet was applied to induce hepatic steatosis. Following steatosis induction, animals received astaxanthin, kokum, or combined supplementation for 90 days. Hepatic fatty acid profile, malondialdehyde (MDA) levels, and lysosomal enzyme activities were subsequently evaluated. Statistical analysis was conducted using one-way ANOVA followed by Tukey\u2019s\n                      <jats:italic>post hoc<\/jats:italic>\n                      test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hepatic steatosis was associated with the accumulation of saturated fatty acids (SFA), elevated MDA concentration, and increased lysosomal esterase (EL) and lysosomal acid lipase (LAL) activities compared with the control group. The proportion of SFA increased from 37.1% in controls to 45.8% in steatotic animals. Supplementation with astaxanthin and kokum promoted a higher degree of fatty acid unsaturation and reduced lipid peroxidation. The DAK group, representing steatotic mice receiving combined supplementation, showed the lowest proportional SFA content among all experimental groups (29.7%) and the lowest MDA concentration among steatotic groups. In addition, supplementation contributed to partial normalization of lysosomal enzyme activities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Supplementation with astaxanthin and kokum, especially in combination, demonstrated a synergistic protective effect by increasing the degree of fatty acid unsaturation, reducing lipid peroxidation, and normalizing lysosomal activity. These findings indicate the therapeutic potential of multi-targeted nutraceutical strategies in the prevention and treatment of NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1841100","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:47:58Z","timestamp":1781848078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatoprotective effects of astaxanthin and kokum on lipid peroxidation and fatty acid profile in mice with diet-induced NAFLD"],"prefix":"10.3389","volume":"17","author":[{"given":"Natalia","family":"Ksepka","sequence":"first","affiliation":[{"name":"Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences","place":["Jastrz\u0119biec, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Wysocki","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences","place":["Jastrz\u0119biec, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maima","family":"Matin","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences","place":["Jastrz\u0119biec, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Lach","sequence":"additional","affiliation":[{"name":"Division of Medical Biology, Institute of Biology, University of Jan Kochanowski","place":["Kielce, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanas G.","family":"Atanasov","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences","place":["Jastrz\u0119biec, Poland"]},{"name":"Ludwig Boltzmann Institute Digital Health and Patient Safety, Medical University of Vienna","place":["Vienna, Austria"]},{"name":"Department of Biochemistry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences","place":["Chennai, Tamil Nadu, India"]},{"name":"Patient Safety & Digital Health (PaDiH) Group, Danube Private University","place":["Krems-Stein, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw O.","family":"Horba\u0144czuk","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences","place":["Jastrz\u0119biec, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"J\u00f3\u017awik","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences","place":["Jastrz\u0119biec, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/CPHY.C170012","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2018","journal-title":"Compr. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/MD12010128","article-title":"Astaxanthin: sources, extraction, stability, biological activities and its commercial applications - a review","volume":"12","author":"Ambati","year":"2014","journal-title":"Mar. Drugs"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ANTIOX10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants"},{"key":"B4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/13813455.2019.1659827","article-title":"Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies","volume":"127","author":"Arya","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.3748\/WJG.V25.I30.4172","article-title":"Reduced lysosomal acid lipase activity: a new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?","volume":"25","author":"Baratta","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.jlr.2023.100427","article-title":"Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase","volume":"64","author":"Bradi\u0107","year":"2023","journal-title":"J. Lipid Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","first-page":"G469","DOI":"10.1152\/AJPGI.00049.2020","article-title":"An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase","volume":"319","author":"Carotti","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ANTIOX10030461","article-title":"Garcinol attenuates lipoprotein(a)-induced oxidative stress and inflammatory cytokine production in ventricular cardiomyocyte through \u03b17-Nicotinic acetylcholine receptor-mediated inhibition of the p38 MAPK and NF-\u03baB signaling pathways","volume":"10","author":"Chang","year":"2021","journal-title":"Antioxidants"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41430-023-01335-2","article-title":"Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic review","volume":"77","author":"Das","year":"2023","journal-title":"Eur. J. Clin. Nutr."},{"key":"B13","article-title":"directive 2010\/63\/eu of the european parliament and of the council of 22 september 2010 on the protection of animals used for scientific purposes","year":"2010"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.3000411","article-title":"Reporting animal research: explanation and elaboration for the arrive guidelines 2.0","volume":"18","author":"du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/J.FREERADBIOMED.2024.01.001","article-title":"Lipid peroxidation products\u2019 role in autophagy regulation","volume":"212","author":"G\u0119gotek","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.intimp.2011.10.004","article-title":"Impact of the carotenoid astaxanthin on phagocytic capacity and ROS\/RNS production of human neutrophils treated with free fatty acids and high glucose","volume":"11","author":"Guerra","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/IJMS232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"896899","DOI":"10.3389\/FPHAR.2022.896899","article-title":"Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/S41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jnutbio.2015.09.015","article-title":"Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL\/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt","volume":"28","author":"Jia","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2478\/aspr-2025-0010","article-title":"Metabolic dysfunction-associated steatotic liver disease: mechanisms, oxidative stress, and the therapeutic potential of garcinol and astaxanthin","volume":"43","author":"Ksepka","year":"2025","journal-title":"Anim. Sci. Pap. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/molecules31020321","article-title":"Antioxidant intervention in NAFLD: astaxanthin and kokum modulate redox status and lysosomal degradation","volume":"31","author":"Ksepka","year":"2026","journal-title":"Molecules"},{"key":"B26","volume-title":"AVMA GUIDELINES FOR THE EUTHANASIA OF ANIMALS: 2020 EDITION AVMA Guidelines for the Euthanasia of Animals: 2020 Edition* Members of the Panel on Euthanasia AVMA Staff Consultants","author":"Leary","year":"2020"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10620","DOI":"10.1021\/ACS.JAFC.2C04476","article-title":"Astaxanthin alleviates nonalcoholic fatty liver disease by regulating the intestinal flora and targeting the AMPK\/Nrf2 signal axis","volume":"70","author":"Li","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/PH14121338","article-title":"Pharmacological activity of Garcinia indica (kokum): an updated review","volume":"14","author":"Lim","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B29","doi-asserted-by":"publisher","first-page":"103863","DOI":"10.1016\/J.JFF.2020.103863","article-title":"Garcinia indica extract standardized for 20% garcinol reduces adipogenesis and high fat diet-induced obesity in mice by alleviating endoplasmic reticulum stress","volume":"67","author":"Majeed","year":"2020","journal-title":"J. Funct. Foods"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/ANTIOX11112217\/S1","article-title":"Role of oxidative stress and lipid peroxidation in the pathophysiology of NAFLD","volume":"11","author":"Mart\u00edn-Fern\u00e1ndez","year":"2022","journal-title":"Antioxidants"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/S41587-024-02410-0","article-title":"The global patent landscape of functional food innovation","volume":"42","author":"Matin","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"105937","DOI":"10.1016\/j.jff.2023.105937","article-title":"Astaxanthin as a metabolic regulator of glucose and lipid homeostasis","volume":"112","author":"Medoro","year":"2024","journal-title":"J. Funct. Foods"},{"key":"B33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/BIOLOGY5040042","article-title":"The potential of non-provitamin a carotenoids for the prevention and treatment of non-alcoholic fatty liver disease","volume":"5","author":"Murillo","year":"2016","journal-title":"Biol. (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.3390\/IJMS24054666","article-title":"Role of plant-derived compounds in the molecular pathways related to inflammation","volume":"24","author":"Ol\u0119dzka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/CPHY.C130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3390\/ANTIOX12081552","article-title":"Preventative and therapeutic effects of astaxanthin on NAFLD","volume":"12","author":"Sayuti","year":"2023","journal-title":"Antioxidants"},{"key":"B38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/GENES14030553","article-title":"Autophagy: a cellular guardian against hepatic lipotoxicity","volume":"14","author":"Sinha","year":"2023","journal-title":"Genes (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/HMER.S201630","article-title":"Lysosomal acid lipase deficiency - early diagnosis is the key. Hepat","volume":"11","author":"Strebinger","year":"2019","journal-title":"Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/J.FREERADBIOMED.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00204-024-03889-X","article-title":"Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review","volume":"99","author":"Svobodov\u00e1","year":"2025","journal-title":"Arch. Toxicol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"101638","DOI":"10.1016\/j.clinre.2021.101638","article-title":"Low levels of lysosomal acid lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease","volume":"45","author":"Thoen","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"131145","DOI":"10.1016\/J.IJBIOMAC.2024.131145","article-title":"Garcinol: a novel and potent inhibitor of hyaluronidase enzyme","volume":"266","author":"Thoyajakshi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/NDT\/GFAD208","article-title":"Natural product drug discovery and drug design: two approaches shaping new pharmaceutical development","volume":"39","author":"Tzvetkov","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"B45","doi-asserted-by":"publisher","first-page":"138760","DOI":"10.1016\/J.IJBIOMAC.2024.138760","article-title":"The role of ALDHs in lipid peroxidation-related diseases","volume":"288","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1111\/bph.15099","article-title":"Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21\/PGC-1\u03b1 pathway","volume":"177","author":"Wu","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00394-024-03560-2","article-title":"The effects of saturated and unsaturated fatty acids on MASLD: a Mendelian randomization analysis and in vivo experiment","volume":"64","author":"Xu","year":"2024","journal-title":"Eur. J. Nutr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.3390\/JCM13164657","article-title":"MASLD-related hepatocarcinoma: special features and challenges","volume":"13","author":"Yag\u00fce-Caballero","year":"2024","journal-title":"J. Clin. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/liv.12685","article-title":"Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis","volume":"35","author":"Yamada","year":"2015","journal-title":"Liver Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J. Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1038\/S41467-023-38165-6","article-title":"Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease","volume":"14","author":"Zeng","year":"2023","journal-title":"Nat. Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"139190","DOI":"10.1016\/J.IJBIOMAC.2024.139190","article-title":"Preventive effect of sea bass protein-based high internal phase pickering emulsion loaded with astaxanthin on DEHP-induced liver lipid metabolism disorder","volume":"292","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"100259","DOI":"10.1016\/J.CRBIOT.2024.100259","article-title":"A review: anti-obesity drug discovery from natural plant metabolites and endogenous peptides","volume":"8","author":"Zhu","year":"2024","journal-title":"Curr. Res. Biotechnol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1841100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:48:00Z","timestamp":1781848080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1841100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":53,"alternative-id":["10.3389\/fphar.2026.1841100"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1841100","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1841100"}}